Home - MS Research Australia
Australia Becomes Second Country to Approve Ocrelizumab for Primary Progressive MS
12 Medications for Relapsing Remitting MS, All 12 have been tested in Trials at Australian Sites
05 June, 2019

From 1 June 2019, generic medications for MS may become available for disease modifying therapies in Australia – in particular for teriflunomide (Aubagio).

secret agents fighting MS
22 May, 2019

Monoclonal antibodies or 'mabs' for short, are the secret agents revolutionising modern medicine and being used to treat various conditions including MS.

22 May, 2019

Dirk Chinchen donates regularly to MS Research Australia via his workplace giving program which is great way to contribute to MS research.

The Australian MS Longitudinal Study

The Australian MS Longitudinal Study (AMSLS) is a long-term, survey-based, tracking study collecting data of practical use for improving the lives of Australians living with MS.

MS Research Australia Clinical Trials Network

The MS Research Australia Clinical Trials Network connects trial sponsors and clinical research organisations with potential trial sites, health professionals and people with MS in Australia and New Zealand.

Vitamin D MS Prevention Trial - PrevANZ

The vitamin D MS Prevention Trial is a clinical trial that will test whether vitamin D supplementation can prevent MS in those at risk of developing the disease.

MS Research Australia Brain Bank

The MS Research Australia Brain Bank coordinates the collection, storage and distribution of neurological tissue from people with MS for use in research.

Dr Jane Desborough
Australian National University, ACT

GRANT TYPE:

Incubator

Dr Lucinda Black
Curtin University, WA

GRANT TYPE:

Travel Award

Dr Lucinda Black
Curtin University, WA

GRANT TYPE:

Fellowship

Professor Rodney Scott
The University of Newcastle, NSW

GRANT TYPE:

Project

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search